Suppr超能文献

添加5微克舒芬太尼或75微克可乐定对分娩时罗哌卡因硬膜外镇痛最低局部镇痛浓度的影响:一项随机对照研究。

Impact of the addition of sufentanil 5 microg or clonidine 75 microg on the minimum local analgesic concentration of ropivacaine for epidural analgesia in labour: a randomized comparison.

作者信息

Dewandre P Y, Kirsch M, Bonhomme V, Columb M, Hans P, Brichant J F

机构信息

Department of Anesthesia and Intensive Care Medicine, CHR de la Citadelle, Liege University Hospital, Liege, Belgium.

出版信息

Int J Obstet Anesth. 2008 Oct;17(4):315-21. doi: 10.1016/j.ijoa.2008.05.005.

Abstract

BACKGROUND

Addition of lipophilic opioids or alpha2-agonists to local anaesthetic solutions reduces local anaesthetic requirements and side effects. While the efficacy and side effects of these adjuvants are dose-related, information about their relative analgesic potencies is lacking, making it difficult to draw meaningful clinical conclusions. The aim of the present study was to assess the relative sparing of ropivacaine by clinically relevant doses of sufentanil and clonidine using the minimum local analgesic concentration (MLAC) model.

METHODS

In this prospective, double-blind study, the sparing effect of sufentanil 5 microg and clonidine 75 microg on the MLAC of ropivacaine administered for labour epidural analgesia was compared in 78 women at <5 cm cervical dilatation. Women were randomly allocated to one of three groups: plain ropivacaine, ropivacaine with sufentanil 5 microg and ropivacaine with clonidine 75 microg.

RESULTS

The MLAC of plain ropivacaine was 0.099% wt/vol (95%CI: 0.090 to 0.109) and was reduced to 0.036% wt/vol (95% CI: 0.024 to 0.049) when combined with sufentanil 5 microg and to 0.036% wt/vol (95% CI: 0.027 to 0.046) with clonidine 75 microg (P < 0.001). The wt/wt local anesthetic sparing potency ratio of sufentanil to clonidine was 15.1 (95% CI: 10.3 to 23.4).

CONCLUSIONS

Sufentanil 5 microg and clonidine 75 microg produce similar reductions in the MLAC of ropivacaine. This finding will make feasible the assessment of the side effects of these adjuvants administered at equipotent doses in further studies.

摘要

背景

在局部麻醉溶液中添加亲脂性阿片类药物或α2-激动剂可降低局部麻醉药的需求量并减少副作用。虽然这些佐剂的疗效和副作用与剂量相关,但缺乏关于它们相对镇痛效力的信息,这使得难以得出有意义的临床结论。本研究的目的是使用最低局部镇痛浓度(MLAC)模型评估临床相关剂量的舒芬太尼和可乐定对罗哌卡因的相对节省作用。

方法

在这项前瞻性、双盲研究中,比较了78名宫颈扩张<5cm的产妇中,5μg舒芬太尼和75μg可乐定对用于分娩硬膜外镇痛的罗哌卡因MLAC的节省作用。产妇被随机分配到三组之一:单纯罗哌卡因、含5μg舒芬太尼的罗哌卡因和含75μg可乐定的罗哌卡因。

结果

单纯罗哌卡因的MLAC为0.099%(重量/体积)(95%CI:0.090至0.109),与5μg舒芬太尼合用时降至0.036%(重量/体积)(95%CI:0.024至0.049),与75μg可乐定合用时降至0.036%(重量/体积)(95%CI:0.027至0.046)(P<0.001)。舒芬太尼与可乐定的重量/重量局部麻醉节省效力比为15.1(95%CI:10.3至23.4)。

结论

5μg舒芬太尼和75μg可乐定对罗哌卡因的MLAC产生相似程度的降低。这一发现将使在进一步研究中评估等效剂量使用这些佐剂时的副作用成为可能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验